Akers Biosciences (AKER) – Business Wire
-
Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger
-
Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Plans to Initiate COVID-19 Inflammatory Depression Trial
-
Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Formation of Scientific Advisory Board
-
Akers Biosciences Announces Shareholder Meeting to Vote on Business Combination with MyMD Pharmaceuticals
-
MyMD Pharmaceuticals Announces New Data on Its Lead Compound MYMD-1 from a Phenotypic Study Performed by Eurofins Discovery
-
Study Identifies Effects of Temperature Changes on SARS-CoV-2 Transmission
-
Akers Biosciences Responds to Erroneous Earnings Call Press Release
-
Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Issuance of Key Patent
-
REMINDER: Akers Biosciences Schedules Conference Call to Discuss Merger with MyMD Pharmaceuticals
-
Akers Biosciences and MyMD Pharmaceuticals Sign Definitive Merger Agreement
Back to AKER Stock Lookup